Johnson & Johnson: Time To Buy Before The Split (NYSE:JNJ)

Summary - JNJ will be spinning off its popular consumer health segment into a separate company called Kenvue. - Medical Devices and Pharmaceutical segments will remain together in which they are the fastest growing segments within the business. - In a time of much uncertainty surrounding 2023, JNJ…#realestateinvestmenttrusts #medtech #tylenol #neutrogena #consumerhealthsegmenttospin #seekingalphacom #abt #aveeno #jnj #abbv

Source: Reuters: Health - December 3, 2022 Category: Consumer Health News Source Type: news